Time from Completion of Neo‐adjuvant Chemotherapy to Surgery: Effects on Outcomes in Breast Cancer Patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Time from Completion of Neo‐adjuvant Chemotherapy to Surgery: Effects on Outcomes in Breast Cancer Patients

Published:2019-08-25 Issue:2 Volume:26 Page:155-161
ISSN:1075-122X
Container-title:The Breast Journal
language:en
Short-container-title:Breast J

Author:

Arciero Cletus¹²^ORCID,Buhariwalla Karen³,Liu Yuan¹⁴,Torres Mylin A.²⁵,Subhedar Preeti¹²

Affiliation:

1. Division of Surgical OncologyEmory University School of Medicine Atlanta GA USA

2. Glenn Family Breast Center Winship Cancer Institute Atlanta GA USA

3. Northside Hospital ‐ Cherokee Canton GA USA

4. Rollins School of Public Health Emory University Atlanta GA USA

5. Department of Radiation OncologyEmory University School of Medicine Atlanta GA USA

Publisher

Hindawi Limited

Subject

Oncology,Surgery,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/tbj.13482

Reference22 articles.

1. Preoperative Chemotherapy: Updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27

2. Neoadjuvant treatment of breast cancer

3. Defining the Benefits of Neoadjuvant Chemotherapy for Breast Cancer

4. RESULTS OF DELAY IN TREATMENT OF BREAST CANCER

5. Time to Surgery and Breast Cancer Survival in the United States

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neoadjuvant pertuzumab plus trastuzumab in combination with chemotherapy for human epidermal growth factor receptor 2 positive breast cancer: a real-world retrospective single-institutional study in China;World Journal of Surgical Oncology;2024-04-06

2. Timing of interval debulking surgery and postoperative chemotherapy after neoadjuvant chemotherapy in advanced epithelial ovarian cancer: a multicenter real-world study;Journal of Ovarian Research;2023-06-27

3. The optimal timing between neoadjuvant therapy and surgery of breast cancer: A brief systematic review of the literature;Critical Reviews in Oncology/Hematology;2023-03

4. An appropriate treatment interval does not affect the prognosis of patients with breast Cancer;Holistic Integrative Oncology;2022-07-05

5. Clinical study on Yanghe decoction in improving neo-adjuvant chemotherapy efficacy and immune function of breast cancer patients;Medicine;2022-03-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3